Use of solid formulations of polyethylene glycol in the treatment of constipation

摘要

The present invention relates to the use of a pharmaceutical composition in solid form, administered orally, comprising at least 98% of polyethylene glycol as sole osmotic laxative agent, in the treatment of constipation and in particular chronic constipation.